Accuray Timeline

Events

• 2026-05-15 - Partnership - Accuray and UW-Madison establish ten-year research collaboration - The agreement focuses on the Stellar adaptive radiation therapy platform. The collaboration covers clinical research, education, training and adaptive-therapy development. It extends a relationship rooted in the technology later commercialised as TomoTherapy. - source: investors.accuray.com
• 2025-10-20 - Executive Hire - Accuray appoints Steve La Neve chief executive - La Neve became CEO on 20 October 2025. Suzanne Winter retired after six years and remained as an adviser through November. Accuray paired the leadership change with a strategic and operational transformation plan. - source: investors.accuray.com
• 2021-01-05 - Regulatory - Accuray receives FDA 510(k) clearance for ClearRT imaging - ClearRT is a helical fan-beam kVCT imaging system for Radixact. Accuray said commercial release was planned for spring 2021. The clearance added integrated imaging capability to the Radixact workflow. - source: investors.accuray.com
• 2016-06-27 - Regulatory - Accuray receives FDA 510(k) clearance for Radixact platform - The FDA clearance covered Radixact Treatment Delivery Platform. Accuray Precision treatment planning and iDMS data management were also cleared. Accuray planned commercial release in fiscal 2017 Q1. - source: investors.accuray.com
• 2012-11-01 - Regulatory - Accuray receives FDA 510(k) clearance for CyberKnife M6 Series - The FDA clearance covered the CyberKnife M6 Series. The system added the InCise Multileaf Collimator to robotic radiosurgery workflows. Accuray said the clearance broadened CyberKnife treatment applications and improved efficiency. - source: investors.accuray.com
• 2011-06-13 - Acquisition - Accuray completes acquisition of TomoTherapy - The transaction completed in June 2011 after the previously announced agreement. The combined installed base rose from 226 to more than 550 systems across 32 countries. TomoTherapy expanded Accuray from radiosurgery into image-guided intensity-modulated… - source: investors.accuray.com
• 2007-02-08 - Market Signal - Accuray prices initial public offering - Accuray offered 10 million company shares and selling stockholders offered 6 million shares. The IPO price was $18 per share. The company identified CyberKnife as its intelligent robotic radiosurgery system. - source: investors.accuray.com